Global Contraceptives Market 2014-2018: Key Vendors are Actavis, Bayer, Johnson & Johnson's, Janssen, Merck & Co, Pfizer and Teva

DUBLIN, Aug. 14, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Contraceptives Market 2014-2018" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

Contraception, also known as birth control or fertility control, refers to the use of methods or drugs or devices to prevent pregnancy as a consequence of sexual intercourse. Contraception methods can be temporary and permanent and are available to men and women. Permanent methods include male sterilization (vasectomy), and female sterilization including tubal occlusion or hysteroscopic sterilisation. Temporary methods can be hormonal and non-hormonal. The non-hormonal methods include condoms, diaphragms, sponges, withdrawal methods, cervical caps, and non-hormonal IUDs. Condoms, diaphragms, sponges, and cervical caps are also referred to as barrier contraception methods. Hormonal methods include oral contraceptive pills, contraceptive transdermal patches, vaginal rings, hormonal IUDs, and vaginal implants. Hormonal methods contain synthetic sex hormones estrogen/progestin or a combination of both which prevent ovulation and thicken cervical mucus in the female. Currently, hormonal methods can only be used by women. The development of a male hormonal contraceptive is an active research area.

The global contraceptives market can be segmented broadly into two divisions: Drugs and Devices. This report covers the present scenario and the growth prospects of the Global Contraceptives market for the period 2013-2018. To calculate the market size, the report considers revenue generated from the sales of various products used for contraception which include:

  • Drugs (Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives)
  • Devices (Male & Female condoms, Diaphragms, IUDs, Vaginal Rings, Female Sponges and Subdermal Contraceptive Implants)

The Global Contraceptives Market 2014-2018 report, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Contraceptives market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Market Segmentation by Products Type

08. Global Contraceptives Drugs Market

09. Global Contraceptives Devices Market

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

19. Vendor Landscape

20. Key Vendor Analysis

21. Other Reports in this Series

Companies Mentioned:

  • Actavis plc
  • Adamis Pharmaceuticals Corp.
  • Agile Therapeutics, Inc.
  • ANI Pharmaceuticals, Inc.
  • Ansell Ltd.
  • Apothecus Pharmaceutical Corp.
  • Bayer AG
  • Blairex Laboratories Inc.
  • Church & Dwight, Co. Inc.
  • Caldwell Consumer Health, LLC.
  • Ferring International Center S.A
  • Fuji Latex Co., Ltd.
  • HLL Lifecare Limited
  • Johnson & Johnson's Janssen Pharmaceuticals, Inc.
  • Karex Berhad
  • Mayer Laboratories
  • Medicines 360
  • Merck & Co.
  • Lipocine Inc.
  • Lupin Pharmaceuticals, Inc.
  • Mylan Laboratories Inc.
  • Okamoto Industries, Inc.
  • Pantarhei Bioscience B.V.
  • Paul Hartmann AG
  • Pfizer, Inc.
  • Reckitt Benckiser Group Plc
  • Teva Pharmaceutical Industries, Ltd
  • The Female Health Company

For more information visit http://www.researchandmarkets.com/research/5kt24m/global

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets



RELATED LINKS
http://www.researchandmarkets.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.